Our Services
Medical Information
Helpful Resources
Published on: 4/21/2026
Lyrica (pregabalin) and Cymbalta (duloxetine) are FDA approved treatments for diabetic nerve pain that work through different mechanisms yet deliver similar pain relief. Lyrica often provides faster relief and can improve sleep but is associated with dizziness, drowsiness, and weight gain, while Cymbalta may boost mood and energy, may take longer for full effect, and carries risks like nausea and increased blood pressure.
Several factors such as dosing schedules, side effects, other health conditions, and cost can influence which is right for you, so see below for detailed information to guide your next steps.
Diabetic neuropathy is a common complication of diabetes that can cause burning, tingling, or stabbing pain in the feet and hands. Two of the most prescribed medications for this nerve pain are Lyrica (pregabalin) and Cymbalta (duloxetine). Understanding how they work, their benefits, side effects, and what to expect can help you and your doctor decide which option is right for you.
Lyrica (pregabalin)
Cymbalta (duloxetine)
Multiple randomized clinical trials and meta-analyses have compared how well these drugs reduce neuropathic pain.
Lyrica
Cymbalta
Head-to-head trials suggest both drugs are similarly effective in reducing average daily pain scores. Individual response varies, so what works best for you may depend on other factors like side effects, other medical conditions, and personal preferences.
Every medication carries potential side effects. Understanding these can help you set realistic expectations and monitor for any issues.
Common (≥10% of patients)
Less common but serious
Common (≥10% of patients)
Less common but serious
Managing Side Effects
Lyrica
Cymbalta
Tapering Off
Before starting either medication, discuss all your current prescriptions, over-the-counter drugs, and supplements with your doctor or pharmacist.
Lyrica Interactions
Cymbalta Interactions
Costs vary by insurance plan, pharmacy discounts, and generic availability.
Check with your insurance provider for formulary status, co-pay tiers, and any required prior authorizations. Many pharmacies also honor discount cards or manufacturer savings programs.
Choosing between Lyrica vs Cymbalta for pain depends on your specific situation:
Consider Lyrica if you:
Consider Cymbalta if you:
Ultimately, both medications are effective. Your doctor may suggest a trial of one, and if you don't get adequate relief or can't tolerate side effects, switch to the other.
Stay in touch with your healthcare provider, especially during the first few weeks:
If you're experiencing burning, tingling, or stabbing pain in your extremities and suspect it may be related to diabetes, use Ubie's free AI-powered Diabetic Neuropathy symptom checker to evaluate your symptoms and better understand your condition before your next doctor's visit.
Remember, this information is not a substitute for professional medical advice. Always speak to your doctor about any symptoms that could be life-threatening or serious, and before starting or changing any medication regimen. Your healthcare provider can help you weigh the benefits and risks of Lyrica vs Cymbalta for pain and find the best strategy to manage your diabetic nerve pain.
(References)
* Kress B, Kress A, Mucke L, Kress D, Mückel H. Pharmacologic Treatment of Painful Diabetic Neuropathy: A Narrative Review. Curr Diab Rep. 2020 Nov 2;20(12):73. doi: 10.1007/s11892-020-01358-1. PMID: 33130985.
* Bril V, England B, Franklin GM, Backonja M, Cohen J, Del Mar C, Friedli WG, Malik RA, Nicholson G, Russell JW, Smith G, Zochodne DW. Treatment of painful diabetic neuropathy: A systematic review and meta-analysis. Neurol Clin Pract. 2018 Feb;8(1):34-52. doi: 10.1212/CPJ.0000000000000410. PMID: 29279010; PMCID: PMC5797378.
* Qing H, Feng C, Jing P. Duloxetine versus pregabalin for painful diabetic neuropathy: a systematic review and meta-analysis of randomized controlled trials. J Pain Res. 2018 Apr 27;11:791-799. doi: 10.2147/JPR.S164741. PMID: 29729227; PMCID: PMC5933390.
* He T, Wang BT, Zhang YJ, Li Q, Guo HY, Liu YL, Li X. Gabapentin vs. pregabalin in the treatment of painful diabetic neuropathy: A systematic review and meta-analysis. Front Pharmacol. 2020 May 12;11:531. doi: 10.3389/fphar.2020.00531. PMID: 32467978; PMCID: PMC7235128.
* Ghasemi K, Rezaei F, Bahadorkhan B, Yekani F, Mirzaei R, Mirahmadizadeh A. Effectiveness and Safety of Oral Medications for Painful Diabetic Neuropathy: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Pain Physician. 2023 Jul;26(4):E335-E355. PMID: 37626359.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.